Kimberly Clark Catches A Downgrade Ahead Of A 'Double Hazard'
Amid heightened competition, rising costs of raw materials, and a weak selling environment, Kimberly Clark Corp (NYSE: KMB) lost the confidence of JPMorgan.
Analysts expect margin pressures and decelerating revenue to cripple the firm’s earnings power potential and thus issued a 2018 earnings per share estimate of $6.09 against management guidance between $6.20 and $6.35.
What’s Going Wrong?
Kimberly Clark is conceding U.S. market share in most product categories, and with retailers opting for more affordable private labels and rival Procter & Gamble Co (NYSE: PG) attempting to prove itself under activist-investor pressures, competition is likely to intensify.
At the same time, the firm continues to struggle in international markets, particularly with a recent Procter & Gamble product launch in China.
“We believe soft top-line trends will be exacerbated by cost pressure from rising pulp and resin prices,” analysts Andrea Teixeira, Christina Brathwaite and Peter Grom wrote in a Friday note. “Input cost inflation will likely more than offset cost reduction efforts via the FORCE program, in our view.”
The Bottom Line
JPMorgan downgraded Kimberly Clark to Underweight and lowered its price target from $135 to $100, noting thesis risk in the potential for large-scale private label contracts with the likes of Amazon.com, Inc. (NASDAQ: AMZN).
At time of publication, shares were trading down 1.8 percent at a rate of $113.49.
Related Links:
Analyst Fights The Temptation To Sell Kimberly Clark
Lightning Round: Jim Cramer Shares His Thoughts On Alibaba, Kimberly Clark And More
____
Image Credit: I, BrokenSphere [GFDL (http://www.gnu.org/copyleft/fdl.html), CC-BY-SA-3.0 (http://creativecommons.org/licenses/by-sa/3.0/) or CC BY-SA 2.5-2.0-1.0 (https://creativecommons.org/licenses/by-sa/2.5-2.0-1.0)], via Wikimedia Commons
Latest Ratings for AMZN
Date | Firm | Action | From | To |
---|---|---|---|---|
Mar 2022 | Deutsche Bank | Initiates Coverage On | Buy | |
Feb 2022 | Tigress Financial | Maintains | Buy | |
Feb 2022 | Credit Suisse | Maintains | Outperform |
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Analyst Color Earnings News Guidance Short Ideas Downgrades Price Target Analyst Ratings Best of Benzinga